4.450EUR0.00%Mkt Cap: 135.44M $P/E: —1d ago
Hyloris Pharmaceuticals SA operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific. The company offers Maxigesic IV for the treatment of post-operat…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap135.44M $
Enterprise Value122.21M $
Revenue (TTM)8.63M $
Gross Profit7.42M $
Net Income (TTM)-6.88M $
Revenue/Share0.3087 USD
Last Price4.450 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees55
CountryBE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)10.00
PEG—
EV/EBITDA-14.01
EV/Revenue14.16
P/S15.69
P/B4.70
EPS (TTM)-0.23
EPS (Forward)0.45
52W Range
4.2006% of range8.400
52W High8.400 EUR
52W Low4.200 EUR
Profitability
Gross Margin94.74%
Oper. Margin-100.50%
EBITDA Margin-101.12%
Profit Margin-87.89%
ROE-23.92%
ROA-18.99%
Growth
Revenue Growth-10.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.60M $
CapEx (TTM)683.70K $
FCF Margin-82.05%
FCF Yield-5.23%
Net Debt-13.22M $
Net Debt/EBITDA1.52
Balance Sheet
Debt/Equity0.06
Current Ratio3.89
Quick Ratio3.76
Book Value/Sh0.9460 EUR
Cash/Share0.4920 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)12.30 EUR
Upside (mean)+176.4%
Target Range6.000 EUR – 20.40 EUR
€6.000+176.4% to mean€20.40
# Analysts3
Ownership
Shares Out.28.00M
Float11.47M
Insiders56.62%
Institutions0.00%
Technical
SMA 504.597 (-3.2%)
SMA 2005.735 (-22.4%)
Beta0.65
S&P 52W Chg18.16%
Avg Vol (30d)1.67K
Avg Vol (10d)2.14K
Technical Indicators
RSI (14)44.1
MACD-0.0466
MACD Signal-0.0318
MACD Hist.-0.0148
BB Upper4.825 EUR
BB Middle4.598 EUR
BB Lower4.370 EUR
BB Width9.92%
ATR (14)0.1536 EUR
Vol Ratio (20d)0.16x